Acceptability of HPV-self Sampling

CompletedOBSERVATIONAL
Enrollment

356

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

July 30, 2017

Study Completion Date

July 30, 2019

Conditions
Cervical Cancer
Interventions
OTHER

questionnaire

The questionnaire will be distributed and collected by the same investigator in one of the eight centers involved in the study. The investigator will verify the inclusion criteria and the absence of exclusion criteria.

Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
collaborator

Dépistages34 (Montpellier - France)

UNKNOWN

collaborator

Adoc11 (Carcassonne - France)

UNKNOWN

collaborator

Maison médicale Paul Valéry - Union Languedoc Mutualité - (Montpellier -France)

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT03137563 - Acceptability of HPV-self Sampling | Biotech Hunter | Biotech Hunter